Patents by Inventor Isolda Casanova Rigat

Isolda Casanova Rigat has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and reagents for efficient and targeted delivery of therapeutic molecules to CXCR4 cells
    Patent number: 11590198
    Abstract: Conjugates comprising a targeting moiety specific for the CXCR4 and based on the polyphemusin-derived peptide and a therapeutic or imaging agent are provided. Therapeutic and diagnostic methods with the conjugates which require specific targeting to CXCR4+cells are provided as well.
    Type: Grant
    Filed: September 21, 2020
    Date of Patent: February 28, 2023
    Assignees: UNIVERSITAT AUTONOMA DE BARCELONA, INSTITUT RECERCA HOSPITAL DE LA SANTA CREU I SANT PAU, CENTRO DE INVESTIGACION BIOMEDICA EN RED EN BIOINGENIERIA BIOMATERIALES Y NANOMEDICINA (CIBER BBN)
    Inventors: Antonio Pedro Villaverde Corrales, Esther Vazquez Gomez, Maria Virtudes Cespedes Navarro, Isolda Casanova Rigat, Neus Ferrer Miralles, Ramon Mangues Bafalluy, Ugutz Unzueta Elorza
  • THERAPEUTIC NANOCONJUGATES AND USES THEREOF
    Publication number: 20220072084
    Abstract: The present invention relates to nanostructured conjugates, more specifically to nanostructured fusion proteins suitable for the selective delivery of their conjugated therapeutic agents to specific cell and tissue types. It also relates to nanoparticles comprising such nanostructured proteins and the therapeutic uses thereof.
    Type: Application
    Filed: January 16, 2020
    Publication date: March 10, 2022
    Inventors: Antonio VILLAVERDE CORRALES, Esther VÁZQUEZ GÓMEZ, Ugutz UNZUETA ELORZA, Ramón MANGUES BAFALLUY, María Virtudes PEDES NAVARRO, Isolda CASANOVA RIGAT, Hector LÓPEZ LAGUNA
  • METHODS AND REAGENTS FOR EFFICIENT AND TARGETED DELIVERY OF THERAPEUTIC MOLECULES TO CXCR4 CELLS
    Publication number: 20210008154
    Abstract: Conjugates comprising a targeting moiety specific for the CXCR4 and based on the polyphemusin-derived peptide and a therapeutic or imaging agent are provided. Therapeutic and diagnostic methods with the conjugates which require specific targeting to CXCR4+cells are provided as well.
    Type: Application
    Filed: September 21, 2020
    Publication date: January 14, 2021
    Inventors: Antonio Pedro VILLAVERDE CORRALES, Esther VAZQUEZ GOMEZ, Maria Virtudes CESPEDES NAVARRO, Isolda CASANOVA RIGAT, Neus FERRER MIRALLES, Ramon MANGUES BAFALLUY, Ugutz UNZUETA ELORZA
  • Methods and reagents for efficient and targeted delivery of therapeutic molecules to CXCR4 cells
    Patent number: 10813975
    Abstract: Conjugates comprising a targeting moiety specific for the CXCR4 and based on the polyphemusin-derived peptide and a therapeutic or imaging agent are provided. Therapeutic and diagnostic methods with the conjugates which require specific targeting to CXCR4+ cells are provided as well.
    Type: Grant
    Filed: February 27, 2019
    Date of Patent: October 27, 2020
    Assignees: UNIVERSITAT AUTONOMA DE BARCELONA, INSTITUT RECERCA HOSPITAL DE LA SANTA CREU I SANT PAU, CENTRO DE INVESTIGACION BIOMEDICA EN RED EN BIOINGENIERIA BIOMATERIALES Y NANOMEDICINA (CIBER BBN)
    Inventors: Antonio Pedro Villaverde Corrales, Esther Vazquez Gomez, Maria Virtudes Cespedes Navarro, Isolda Casanova Rigat, Neus Ferrer Miralles, Ramon Mangues Bafalluy, Ugutz Unzueta Elorza
  • NANOSTRUCTURED PROTEINS AND USES THEREOF
    Publication number: 20200239529
    Abstract: The present invention relates to nanostructured proteins, more specifically to fusion proteins suitable for their selective delivery to specific cell and tissue types. It also relates to nanoparticles comprising such nanostructured proteins, as well as nucleic acids, vectors, cells that comprise said proteins, and the therapeutic uses thereof.
    Type: Application
    Filed: May 7, 2018
    Publication date: July 30, 2020
    Inventors: Antonio VILLAVERDE CORRALES, Esther VÁZQUEZ GÓMEZ, Naroa SERNA ROMERO, Laura SÁNCHEZ GARC?A, Ugutz UNZUETA ELORZA, Ramón MANGUES BAFALLUY, María Virtudes CÉSPEDES NAVARRO, Isolda CASANOVA RIGAT
  • THERAPEUTIC NANOCONJUGATES AND USES THEREOF
    Publication number: 20200223893
    Abstract: The present invention relates to nanostructured conjugates, more specifically to nanostructured fusion proteins suitable for the selective delivery of their conjugated therapeutic agents to specific cell and tissue types. It also relates to nanoparticles comprising such nanostructured proteins and the therapeutic uses thereof.
    Type: Application
    Filed: July 16, 2018
    Publication date: July 16, 2020
    Inventors: Antonio Pedro VILLAVERDE CORRALES, Esther VÁZQUEZ GÓMEZ, Ugutz UNZUETA ELORZA, Ramón MANGUES BAFALLUY, María Virtudes CÉSPEDES NAVARRO, Isolda CASANOVA RIGAT
  • METHODS AND REAGENTS FOR EFFICIENT AND TARGETED DELIVERY OF THERAPEUTIC MOLECULES TO CXCR4 CELLS
    Publication number: 20190183968
    Abstract: Conjugates comprising a targeting moiety specific for the CXCR4 and based on the polyphemusin-derived peptide and a therapeutic or imaging agent are provided. Therapeutic and diagnostic methods with the conjugates which require specific targeting to CXCR4+ cells are provided as well.
    Type: Application
    Filed: February 27, 2019
    Publication date: June 20, 2019
    Inventors: Antonio Pedro VILLAVERDE CORRALES, Esther VAZQUEZ GOMEZ, Maria Virtudes CESPEDES NAVARRO, Isolda CASANOVA RIGAT, Neus FERRER MIRALLES, Ramon MANGUES BAFALLUY, Ugutz UNZUETA ELORZA
  • Methods and reagents for efficient and targeted delivery of therapeutic molecules to CXCR4 cells
    Patent number: 10265371
    Abstract: Conjugates comprising a targeting moiety specific for the CXCR4 and based on the polyphemusin-derived peptide and a therapeutic or imaging agent are provided. Therapeutic and diagnostic methods with the conjugates which require specific targeting to CXCR4+ cells are provided as well.
    Type: Grant
    Filed: January 10, 2017
    Date of Patent: April 23, 2019
    Assignees: UNIVERSITAT AUTONOMA DE BARCELONA, INSTITUT RECERCA HOSPITAL DE LA SANTA CREU I SANT PAU, CENTRO DE INVESTIGACION BIOMEDICA EN RED EN BIOINGENIERIA BIOMATERIALES Y NANOMEDICINA (CIBER BBN)
    Inventors: Antonio Pedro Villaverde Corrales, Esther Vazquez Gomez, Maria Virtudes Cespedes Navarro, Isolda Casanova Rigat, Neus Ferrer Miralles, Ramon Mangues Bafalluy, Ugutz Unzueta Elorza
  • METHODS AND REAGENTS FOR EFFICIENT AND TARGETED DELIVERY OF THERAPEUTIC MOLECULES TO CXCR4 CELLS
    Publication number: 20170209590
    Abstract: Conjugates comprising a targeting moiety specific for the CXCR4 and based on the polyphemusin-derived peptide and a therapeutic or imaging agent are provided. Therapeutic and diagnostic methods with the conjugates which require specific targeting to CXCR4+ cells are provided as well.
    Type: Application
    Filed: January 10, 2017
    Publication date: July 27, 2017
    Inventors: Antonio Pedro VILLAVERDE CORRALES, Esther VAZQUEZ GOMEZ, Maria Virtudes CESPEDES NAVARRO, Isolda CASANOVA RIGAT, Neus FERRER MIRALLES, Ramon MANGUES BAFALLUY, Ugutz UNZUETA ELORZA
  • Methods and reagents for efficient and targeted delivery of therapeutic molecules to CXCR4 cells
    Patent number: 9580468
    Abstract: Conjugates comprising a targeting moiety specific for the CXCR4 and based on the polyphemusin-derived peptide and a therapeutic or imaging agent are provided. Therapeutic and diagnostic methods with the conjugates which require specific targeting to CXCR4+ cells are provided as well.
    Type: Grant
    Filed: January 13, 2012
    Date of Patent: February 28, 2017
    Assignees: UNIVERSITAT AUTONOMA DE BARCELONA, INSTITUT RECERCA HOSPITAL DE LA SANTA CREU I SANT PAU HOSPITAL DE SANT PAU, CENTRE DE INVESTIGACION BIOMEDICA EN RED BIOINGENIERA BIOMATERIALS Y NANOMEDICINA (CIBER BBN)
    Inventors: Antonio Pedro Villaverde Corrales, Esther Vázquez Gómez, Neus Ferrer Miralles, Ugutz Unzueta Elorza, Ramón Mangues Bafalluy, Maria Virtudes Céspedes Navarro, Isolda Casanova Rigat
  • METHODS AND REAGENTS FOR EFFICIENT AND TARGETED DELIVERY OF THERAPEUTIC MOLECULES TO CXCR4 CELLS
    Publication number: 20140094404
    Abstract: The invention relates to conjugates comprising a targeting moiety specific for the CXCR4 based on the polyphemusin-derived peptide and a therapeutic or imaging agent. The invention relates as well to the application of said conjugates for the therapy and diagnostics which require the specific targeting to CXCR4+ cells.
    Type: Application
    Filed: January 13, 2012
    Publication date: April 3, 2014
    Inventors: Antonio Pedro Villaverde Corrales, Esther Vázquez Gómez, Neus Ferrer Miralles, Ugutz Unzueta Elorza, Ramón Mangues Bafalluy, Maria Virtudes Céspedes Navarro, Isolda Casanova Rigat